| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MicroRNAs | 26 | 2018 | 704 | 4.620 |
Why?
|
| RNA-Binding Proteins | 23 | 2025 | 447 | 3.960 |
Why?
|
| Protein Biosynthesis | 5 | 2025 | 331 | 2.620 |
Why?
|
| RNA, Transfer | 5 | 2025 | 93 | 2.540 |
Why?
|
| Codon | 4 | 2025 | 58 | 2.530 |
Why?
|
| Methyltransferases | 7 | 2025 | 67 | 2.480 |
Why?
|
| RNA, Messenger | 10 | 2025 | 1572 | 2.400 |
Why?
|
| Embryonic Stem Cells | 8 | 2015 | 156 | 2.110 |
Why?
|
| RNA Processing, Post-Transcriptional | 7 | 2022 | 103 | 1.790 |
Why?
|
| DNA-Binding Proteins | 7 | 2015 | 1220 | 1.310 |
Why?
|
| Neoplasms | 4 | 2025 | 1357 | 1.200 |
Why?
|
| Carcinogenesis | 2 | 2021 | 133 | 1.150 |
Why?
|
| RNA Nucleotidyltransferases | 4 | 2016 | 11 | 1.100 |
Why?
|
| Adenosine Deaminase | 2 | 2025 | 22 | 1.090 |
Why?
|
| RNA Editing | 2 | 2025 | 24 | 1.090 |
Why?
|
| Exoribonucleases | 3 | 2016 | 30 | 0.970 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2025 | 582 | 0.950 |
Why?
|
| Adenosine | 4 | 2024 | 78 | 0.940 |
Why?
|
| tRNA Methyltransferases | 2 | 2025 | 10 | 0.930 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2014 | 660 | 0.890 |
Why?
|
| Cell Cycle | 3 | 2024 | 396 | 0.880 |
Why?
|
| Serine | 1 | 2024 | 90 | 0.830 |
Why?
|
| RNA Interference | 7 | 2016 | 640 | 0.740 |
Why?
|
| DNA Damage | 1 | 2024 | 292 | 0.730 |
Why?
|
| Mice | 27 | 2025 | 11085 | 0.730 |
Why?
|
| Eukaryotic Initiation Factor-3 | 2 | 2018 | 4 | 0.700 |
Why?
|
| Animals | 34 | 2025 | 21292 | 0.680 |
Why?
|
| Uridine | 3 | 2016 | 23 | 0.660 |
Why?
|
| Ribosomes | 2 | 2020 | 170 | 0.650 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 702 | 0.650 |
Why?
|
| Transcription Factors | 6 | 2017 | 1549 | 0.630 |
Why?
|
| Denture Bases | 1 | 2019 | 1 | 0.630 |
Why?
|
| Candida albicans | 1 | 2019 | 75 | 0.590 |
Why?
|
| Gene Expression Regulation | 6 | 2016 | 1633 | 0.570 |
Why?
|
| Pluripotent Stem Cells | 4 | 2016 | 72 | 0.540 |
Why?
|
| HEK293 Cells | 5 | 2024 | 616 | 0.540 |
Why?
|
| RNA Stability | 3 | 2020 | 104 | 0.530 |
Why?
|
| Cell Line, Tumor | 9 | 2025 | 1556 | 0.530 |
Why?
|
| Humans | 44 | 2025 | 64729 | 0.520 |
Why?
|
| Software | 1 | 2020 | 392 | 0.510 |
Why?
|
| Ribonuclease III | 4 | 2015 | 86 | 0.500 |
Why?
|
| Gene Silencing | 4 | 2021 | 418 | 0.500 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2016 | 6 | 0.500 |
Why?
|
| RNA Cleavage | 1 | 2016 | 19 | 0.490 |
Why?
|
| Signal Recognition Particle | 1 | 2016 | 39 | 0.490 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2016 | 21 | 0.480 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 105 | 0.460 |
Why?
|
| Cell Proliferation | 8 | 2025 | 1029 | 0.460 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 57 | 0.430 |
Why?
|
| Protein Binding | 6 | 2020 | 1640 | 0.400 |
Why?
|
| Exonucleases | 1 | 2013 | 6 | 0.400 |
Why?
|
| Wilms Tumor | 1 | 2013 | 4 | 0.400 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1984 | 0.400 |
Why?
|
| Fetal Macrosomia | 1 | 2013 | 13 | 0.390 |
Why?
|
| Ribonucleases | 1 | 2013 | 33 | 0.390 |
Why?
|
| Cell Lineage | 3 | 2021 | 281 | 0.390 |
Why?
|
| Cell Differentiation | 6 | 2024 | 1381 | 0.390 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 364 | 0.380 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 364 | 0.380 |
Why?
|
| Argonaute Proteins | 2 | 2013 | 151 | 0.370 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 58 | 0.370 |
Why?
|
| Signal Transduction | 5 | 2016 | 3147 | 0.340 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 219 | 0.310 |
Why?
|
| Base Sequence | 5 | 2015 | 1326 | 0.290 |
Why?
|
| Cells, Cultured | 6 | 2017 | 2188 | 0.290 |
Why?
|
| Proteins | 2 | 2013 | 763 | 0.270 |
Why?
|
| Leukemia | 2 | 2019 | 61 | 0.270 |
Why?
|
| Mesoderm | 1 | 2008 | 88 | 0.270 |
Why?
|
| Nucleic Acid Conformation | 3 | 2018 | 240 | 0.270 |
Why?
|
| Methylation | 3 | 2024 | 129 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 235 | 0.260 |
Why?
|
| Cell Line | 5 | 2015 | 2036 | 0.250 |
Why?
|
| HeLa Cells | 4 | 2018 | 540 | 0.250 |
Why?
|
| Transfection | 3 | 2016 | 700 | 0.250 |
Why?
|
| Biofilms | 2 | 2019 | 85 | 0.240 |
Why?
|
| Lung | 2 | 2021 | 965 | 0.240 |
Why?
|
| RNA, Small Interfering | 5 | 2019 | 969 | 0.240 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 217 | 0.240 |
Why?
|
| Benzodiazepines | 2 | 2017 | 105 | 0.240 |
Why?
|
| Myocardium | 1 | 2008 | 298 | 0.240 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 195 | 0.240 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 677 | 0.230 |
Why?
|
| Transfer RNA Aminoacylation | 1 | 2025 | 2 | 0.230 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 764 | 0.220 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2019 | 191 | 0.220 |
Why?
|
| Anticodon | 1 | 2024 | 12 | 0.220 |
Why?
|
| Cytidine | 1 | 2024 | 15 | 0.210 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2021 | 299 | 0.210 |
Why?
|
| Pancreas | 1 | 2024 | 154 | 0.210 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2025 | 204 | 0.200 |
Why?
|
| RNA Precursors | 2 | 2015 | 78 | 0.200 |
Why?
|
| Zebrafish Proteins | 1 | 2025 | 168 | 0.200 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 1285 | 0.200 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 285 | 0.200 |
Why?
|
| Transcription, Genetic | 4 | 2016 | 907 | 0.200 |
Why?
|
| Up-Regulation | 3 | 2016 | 373 | 0.190 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1211 | 0.190 |
Why?
|
| Amino Acid Sequence | 4 | 2016 | 1592 | 0.190 |
Why?
|
| DNA Repair | 1 | 2024 | 251 | 0.190 |
Why?
|
| RNA | 2 | 2020 | 426 | 0.190 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 793 | 0.180 |
Why?
|
| Guanosine | 1 | 2021 | 11 | 0.180 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2019 | 33 | 0.180 |
Why?
|
| CDC2 Protein Kinase | 1 | 2021 | 38 | 0.170 |
Why?
|
| Janus Kinase 1 | 1 | 2021 | 15 | 0.170 |
Why?
|
| Janus Kinase 2 | 1 | 2021 | 21 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 543 | 0.170 |
Why?
|
| Oncogenes | 1 | 2021 | 70 | 0.170 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 79 | 0.170 |
Why?
|
| Wnt Signaling Pathway | 2 | 2019 | 85 | 0.170 |
Why?
|
| Models, Biological | 3 | 2012 | 1203 | 0.170 |
Why?
|
| Anemia, Diamond-Blackfan | 1 | 2020 | 8 | 0.170 |
Why?
|
| Complement Activation | 1 | 2021 | 50 | 0.170 |
Why?
|
| Thyroid Neoplasms | 1 | 2021 | 77 | 0.170 |
Why?
|
| RNA, Neoplasm | 1 | 2020 | 36 | 0.160 |
Why?
|
| Tripartite Motif Proteins | 1 | 2020 | 42 | 0.160 |
Why?
|
| 3T3 Cells | 1 | 2020 | 111 | 0.160 |
Why?
|
| Zebrafish | 3 | 2025 | 369 | 0.160 |
Why?
|
| Open Reading Frames | 1 | 2020 | 84 | 0.160 |
Why?
|
| Proteomics | 1 | 2022 | 291 | 0.160 |
Why?
|
| Hep G2 Cells | 2 | 2020 | 28 | 0.160 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 51 | 0.160 |
Why?
|
| Dentures | 1 | 2019 | 1 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 66 | 0.160 |
Why?
|
| Acrylic Resins | 1 | 2019 | 21 | 0.150 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 129 | 0.150 |
Why?
|
| Caffeine | 1 | 2019 | 46 | 0.150 |
Why?
|
| Mouse Embryonic Stem Cells | 2 | 2016 | 28 | 0.150 |
Why?
|
| Glucose | 2 | 2013 | 476 | 0.150 |
Why?
|
| Asparaginase | 1 | 2019 | 1 | 0.150 |
Why?
|
| Wnt3A Protein | 1 | 2019 | 3 | 0.150 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2019 | 4 | 0.150 |
Why?
|
| Rhabdomyolysis | 1 | 2019 | 23 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 178 | 0.150 |
Why?
|
| Cyclization | 1 | 2018 | 3 | 0.150 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 82 | 0.140 |
Why?
|
| Polyribosomes | 1 | 2018 | 16 | 0.140 |
Why?
|
| Cell Survival | 2 | 2021 | 581 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 227 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 171 | 0.140 |
Why?
|
| Nicotine | 1 | 2019 | 118 | 0.140 |
Why?
|
| Cell Movement | 2 | 2021 | 475 | 0.140 |
Why?
|
| Epithelial Cells | 1 | 2021 | 417 | 0.140 |
Why?
|
| Education, Dental, Graduate | 1 | 2018 | 5 | 0.140 |
Why?
|
| Mice, Nude | 1 | 2018 | 286 | 0.140 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2018 | 54 | 0.140 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 172 | 0.130 |
Why?
|
| Gene Expression | 3 | 2015 | 856 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 304 | 0.130 |
Why?
|
| Click Chemistry | 1 | 2017 | 10 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 214 | 0.130 |
Why?
|
| Sequence Alignment | 2 | 2015 | 300 | 0.130 |
Why?
|
| Recombinant Proteins | 2 | 2020 | 710 | 0.130 |
Why?
|
| Epigenomics | 1 | 2017 | 62 | 0.130 |
Why?
|
| A549 Cells | 1 | 2016 | 39 | 0.120 |
Why?
|
| Eukaryotic Initiation Factor-2 | 2 | 2013 | 15 | 0.120 |
Why?
|
| Dentin | 1 | 2015 | 5 | 0.120 |
Why?
|
| Porphyromonas gingivalis | 1 | 2015 | 17 | 0.120 |
Why?
|
| Fetal Hemoglobin | 1 | 2015 | 15 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 640 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 2016 | 127 | 0.110 |
Why?
|
| Spliceosomes | 1 | 2015 | 42 | 0.110 |
Why?
|
| Endonucleases | 1 | 2015 | 84 | 0.110 |
Why?
|
| Cell Cycle Proteins | 2 | 2015 | 403 | 0.110 |
Why?
|
| Genes, Homeobox | 1 | 2014 | 24 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2015 | 185 | 0.110 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 52 | 0.110 |
Why?
|
| Biological Transport | 1 | 2015 | 292 | 0.110 |
Why?
|
| Trans-Activators | 1 | 2016 | 321 | 0.110 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2015 | 98 | 0.100 |
Why?
|
| Inflammation | 1 | 2021 | 1185 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 348 | 0.100 |
Why?
|
| Cell Count | 1 | 2014 | 129 | 0.100 |
Why?
|
| Molecular Structure | 1 | 2015 | 315 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 333 | 0.100 |
Why?
|
| Uridine Monophosphate | 1 | 2013 | 8 | 0.100 |
Why?
|
| Carboxypeptidases | 1 | 2013 | 9 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 112 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 130 | 0.100 |
Why?
|
| Fertility | 1 | 2013 | 83 | 0.100 |
Why?
|
| Brain | 1 | 2021 | 1594 | 0.090 |
Why?
|
| CRISPR-Cas Systems | 1 | 2016 | 367 | 0.090 |
Why?
|
| Germ Cells | 1 | 2013 | 118 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2013 | 336 | 0.090 |
Why?
|
| Gene Editing | 1 | 2016 | 327 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2011 | 266 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2012 | 364 | 0.090 |
Why?
|
| Genome-Wide Association Study | 3 | 2021 | 358 | 0.090 |
Why?
|
| Cell Nucleolus | 1 | 2011 | 71 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 512 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2011 | 47 | 0.080 |
Why?
|
| Multienzyme Complexes | 1 | 2011 | 88 | 0.080 |
Why?
|
| Transcriptome | 1 | 2014 | 396 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2011 | 82 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 897 | 0.080 |
Why?
|
| Cytidine Deaminase | 1 | 2011 | 86 | 0.080 |
Why?
|
| Hematopoiesis | 2 | 2021 | 127 | 0.080 |
Why?
|
| Cellular Senescence | 2 | 2021 | 120 | 0.080 |
Why?
|
| RNA Splicing | 2 | 2021 | 164 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2019 | 2150 | 0.080 |
Why?
|
| THP-1 Cells | 2 | 2019 | 23 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 801 | 0.070 |
Why?
|
| Zinc Fingers | 1 | 2009 | 105 | 0.070 |
Why?
|
| Catalysis | 1 | 2009 | 164 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2009 | 259 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2025 | 960 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2008 | 6 | 0.070 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2008 | 35 | 0.070 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2008 | 111 | 0.070 |
Why?
|
| Carcinoma, Embryonal | 1 | 2008 | 5 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 203 | 0.070 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2008 | 38 | 0.070 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 97 | 0.070 |
Why?
|
| Oocytes | 1 | 2009 | 201 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2011 | 632 | 0.070 |
Why?
|
| Cellular Reprogramming | 1 | 2008 | 41 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2008 | 131 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2011 | 563 | 0.070 |
Why?
|
| Protein Stability | 2 | 2019 | 93 | 0.070 |
Why?
|
| Homeostasis | 1 | 2010 | 378 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2008 | 324 | 0.060 |
Why?
|
| Kinetics | 1 | 2008 | 758 | 0.060 |
Why?
|
| Female | 4 | 2018 | 33739 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2008 | 301 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 572 | 0.060 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2025 | 4 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 198 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 3460 | 0.050 |
Why?
|
| Complement Factor B | 1 | 2021 | 11 | 0.040 |
Why?
|
| Complement C3a | 1 | 2021 | 7 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2021 | 197 | 0.040 |
Why?
|
| Calmodulin | 1 | 2020 | 23 | 0.040 |
Why?
|
| Erythropoiesis | 1 | 2020 | 39 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2021 | 98 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2020 | 115 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 86 | 0.040 |
Why?
|
| Protein Transport | 1 | 2021 | 409 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 452 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2021 | 204 | 0.040 |
Why?
|
| Point Mutation | 1 | 2020 | 168 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 311 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2019 | 13 | 0.040 |
Why?
|
| Heart | 1 | 2021 | 295 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 110 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 117 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 134 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 506 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 201 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 311 | 0.030 |
Why?
|
| Schools, Dental | 1 | 2018 | 3 | 0.030 |
Why?
|
| Proteolysis | 1 | 2019 | 154 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2018 | 203 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 352 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 526 | 0.030 |
Why?
|
| Cell Death | 1 | 2019 | 288 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 130 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 312 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 851 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 1210 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2017 | 292 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1689 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 153 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2017 | 126 | 0.030 |
Why?
|
| Polydioxanone | 1 | 2015 | 1 | 0.030 |
Why?
|
| Genes, myc | 1 | 2015 | 18 | 0.030 |
Why?
|
| Metronidazole | 1 | 2015 | 9 | 0.030 |
Why?
|
| Azepines | 1 | 2015 | 22 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2015 | 25 | 0.030 |
Why?
|
| gamma-Globins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 610 | 0.030 |
Why?
|
| Clone Cells | 1 | 2015 | 112 | 0.030 |
Why?
|
| Minocycline | 1 | 2015 | 28 | 0.030 |
Why?
|
| Gene Order | 1 | 2015 | 33 | 0.030 |
Why?
|
| Erythroid Cells | 1 | 2015 | 13 | 0.030 |
Why?
|
| Nanofibers | 1 | 2015 | 20 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1094 | 0.030 |
Why?
|
| beta Catenin | 1 | 2015 | 99 | 0.030 |
Why?
|
| Triazoles | 1 | 2015 | 63 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2015 | 166 | 0.030 |
Why?
|
| Retroviridae | 1 | 2015 | 75 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 295 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 129 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 493 | 0.030 |
Why?
|
| Dwarfism | 1 | 2013 | 15 | 0.030 |
Why?
|
| Growth and Development | 1 | 2013 | 10 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 242 | 0.030 |
Why?
|
| Fetus | 1 | 2013 | 102 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2015 | 350 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2013 | 76 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 682 | 0.020 |
Why?
|
| Testis | 1 | 2013 | 161 | 0.020 |
Why?
|
| Polymers | 1 | 2015 | 328 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 405 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 870 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2015 | 718 | 0.020 |
Why?
|
| Chromatin | 1 | 2015 | 640 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 419 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 987 | 0.020 |
Why?
|
| Male | 3 | 2019 | 30790 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2753 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2270 | 0.020 |
Why?
|
| Binding Sites | 1 | 2011 | 920 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 1580 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2015 | 903 | 0.020 |
Why?
|
| Lymphoma, T-Cell | 1 | 2008 | 21 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2008 | 51 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2011 | 412 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 50 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2008 | 70 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 1157 | 0.020 |
Why?
|
| United States | 1 | 2018 | 8041 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 727 | 0.010 |
Why?
|
| Obesity | 1 | 2011 | 1263 | 0.010 |
Why?
|